Facilitated By

San Antonio Medical Foundation

News

  • Traders Are Bearish Anixa Biosciences, Inc. (ANIX) After The Stock Formed Bearish Multiple ...

    The stock of Anixa Biosciences, Inc. (ANIX) shows a multiple bottoms pattern ... “Anixa Biosciences Announces Presentation at the 2019 San Antonio ...

  • Recon: FDA Authorizes First Newborn DMD Screening Test; Amgen, UCB Osteoporosis Drug ...

    Pharmaceutical & Biotechnology: Study Results, Filings & Designations ... Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of ... Drug Delivery Technology To Be Presented At San Antonio Breast Cancer ...

  • Unplugged: World Cup skiers find creative ways to decompress

    She has a computer science degree from Vermont and is now working toward a biomedical engineering degree through the University of Montreal.

  • Silverback Therapeutics Announces Preclinical Data at 2019 San Antonio Breast Cancer ...

    SAN ANTONIO--(BUSINESS WIRE)--Dec 12, 2019-- ... BIOTECHNOLOGY HEALTH CONSUMER PHARMACEUTICAL SCIENCE ONCOLOGY.

  • Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 ...

    Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of ... HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio ...